Charles York
Director of Finance/CFO at DAY ONE BIOPHARMACEUTICALS, INC.
Net worth: 5 M $ as of 2024-03-30
Profile
Charles N.
York is currently the Chief Operating & Financial Officer at DOT Therapeutics-2, Inc. and the Chief Operating & Financial Officer, Secretary at Day One Biopharmaceuticals, Inc. Previously, he worked as the Controller at Astrotech Corp.
from 2009 to 2012 and as the Chief Financial Officer, Secretary & VP at Spyre Therapeutics, Inc. from 2014 to 2021.
Mr. York obtained his undergraduate degree from the University of Connecticut in 1999 and his MBA from the McCombs School of Business in 2006.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-02-15 | 277,754 ( 0.32% ) | 5 M $ | 2024-03-30 |
Charles York active positions
| Companies | Position | Start |
|---|---|---|
| DAY ONE BIOPHARMACEUTICALS, INC. | Director of Finance/CFO | 2021-01-31 |
DOT Therapeutics-2, Inc.
 DOT Therapeutics-2, Inc. Pharmaceuticals: MajorHealth Technology DOT Therapeutics-2, Inc. develops new therapies that change the outcome for people of all ages living with cancer. The company was founded by Julie Grant and Samuel Blackman and is headquartered in South San Francisco, CA. | Director of Finance/CFO | 2021-02-16 |
Former positions of Charles York
| Companies | Position | End |
|---|---|---|
| SPYRE THERAPEUTICS, INC. | Director of Finance/CFO | 2021-02-11 |
| ASTROTECH CO. | Comptroller/Controller/Auditor | 2012-07-31 |
Training of Charles York
| University of Connecticut | Undergraduate Degree |
| McCombs School of Business | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| ASTROTECH CO. | Electronic Technology |
| SPYRE THERAPEUTICS, INC. | Health Technology |
| DAY ONE BIOPHARMACEUTICALS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
DOT Therapeutics-2, Inc.
DOT Therapeutics-2, Inc. Pharmaceuticals: MajorHealth Technology DOT Therapeutics-2, Inc. develops new therapies that change the outcome for people of all ages living with cancer. The company was founded by Julie Grant and Samuel Blackman and is headquartered in South San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Charles York
